AFP and hepatocellular carcinoma: If the traditional serum diagnostic markers of HCC, AFP, and exosomes are jointly applied to the diagnosis of early-stage HCC, the diagnostic rate of early-stage HCC patients can be improved, which is crucial for prolonging the survival time of HCC patients.